KRT19 and cancer: At the same time, CTCs express cancer stem cell markers, such as CD90, CD133, EpCAM, CK19 and Nanog, etc. [18,108,109], which supports the concept of circulating cancer stem cells (CSCs) as the cell origin for the wide spreading of HCC in the body [18].